Naason Science ramps up services in response to COVID-19 global outbreak.

Naason Science
Naason Science
  • Home
  • Research
    • Preclinical Research
    • Neurology Models
    • Pain Models
    • Oncology Models
    • Ophthalmology Models
    • Orthopedic Models
    • Metabolic Disease Models
    • Psychiatric Models
  • Discovery
    • Areas of Expertise
    • Capabilities
  • News
  • Careers
    • Careers
    • Naason Team
  • Contact
  • Portal
  • More
    • Home
    • Research
      • Preclinical Research
      • Neurology Models
      • Pain Models
      • Oncology Models
      • Ophthalmology Models
      • Orthopedic Models
      • Metabolic Disease Models
      • Psychiatric Models
    • Discovery
      • Areas of Expertise
      • Capabilities
    • News
    • Careers
      • Careers
      • Naason Team
    • Contact
    • Portal
  • Home
  • Research
  • Discovery
  • News
  • Careers
  • Contact
  • Portal

Psychiatric Disease Models

PTSD in rats

PTSD is a serious anxiety disorder that can lead to intense fear and anxiety. Current medication is unspecific and ineffective, with a number of side effects.  Naason Science is part of a consortium for the development of a new potential treatment to reduce fear memory in post-traumatic stress disorder (PTSD).   By selectively targeting mGlu7 with NAMs, the brain circuitries involved in fear and anxiety can be precisely modulated, potentially resulting in higher efficacy and fewer side effects. 


Please find more information about the project here.

image640

For more information please

Contact us

© 2021 Naason Science Inc. All rights reserved.

  • Home
  • Preclinical Research
  • Areas of Expertise
  • News
  • Careers
  • Contact
  • Privacy & Terms

Welcome to Naason Science website!

Our website uses cookies. By continuing to use this site, you accept our use of cookies.

DeclineAccept